Ning-Fang Ma

Affiliated Cancer Hospital and Institute of Guangzhou Medical University

Affiliated withAffiliated Cancer Hospital and Institute of Guangzhou Medical University Guangzhou Medical University

Research Area

Cancer Research

Biography

Ning-Fang Ma has not added Biography.
If you are Ning-Fang Ma and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 1	2023

Other Publications

Article	Year
CaMKII-mediated Beclin 1 phosphorylation regulates autophagy that promotes degradation of Id and neuroblastoma cell differentiation. Nature communications\| PubMed ID: 29079782	2017
Eukaryotic Initiation Factor 5A2 Contributes to the Maintenance of CD133(+) Hepatocellular Carcinoma Cells via the c-Myc/microRNA-29b Axis. Stem cells (Dayton, Ohio)\| PubMed ID: 29119708	2018
CSTF2-Induced Shortening of the 3'UTR Promotes the Pathogenesis of Urothelial Carcinoma of the Bladder. Cancer research\| PubMed ID: 30143523	2018
A Novel Regulatory Axis, CHD1L-MicroRNA 486-Matrix Metalloproteinase 2, Controls Spermatogonial Stem Cell Properties. Molecular and cellular biology\| PubMed ID: 30455250	2019
CHD1L contributes to cisplatin resistance by upregulating the ABCB1-NF-κB axis in human non-small-cell lung cancer. Cell death & disease\| PubMed ID: 30718500	2019
Identification of prognostic claudins signature in hepatocellular carcinoma from a hepatocyte differentiation model. Hepatology international\| PubMed ID: 32304089	2020
PARP inhibitor Olaparib overcomes Sorafenib resistance through reshaping the pluripotent transcriptome in hepatocellular carcinoma. Molecular cancer\| PubMed ID: 33485358	2021
Targeting tumor lineage plasticity in hepatocellular carcinoma using an anti-CLDN6 antibody-drug conjugate. Science translational medicine\| PubMed ID: 33536280	2021
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition). Autophagy\| PubMed ID: 33634751	2021
Diversity roles of CHD1L in normal cell function and tumorigenesis. Biomarker research\| PubMed ID: 33663617	2021
CHD1L prevents lipopolysaccharide-induced hepatocellular carcinomar cell death by activating hnRNP A2/B1-nmMYLK axis. Cell death & disease\| PubMed ID: 34588420	2021
CHD1L augments autophagy-mediated migration of hepatocellular carcinoma through targeting ZKSCAN3. Cell death & disease\| PubMed ID: 34654797	2021
Molecular subclassification of gastrointestinal cancers based on cancer stem cell traits. Experimental hematology & oncology\| PubMed ID: 34774101	2021
Growth differentiation factor 1-induced tumour plasticity provides a therapeutic window for immunotherapy in hepatocellular carcinoma. Nature communications\| PubMed ID: 34880251	2021
Correction to: CHD1L prevents lipopolysaccharide-induced hepatocellular carcinomar cell death by activating hnRNP A2/B1-nmMYLK axis. Cell death & disease\| PubMed ID: 35236830	2022
Identification and functional characterization of potential oncofetal targets in human hepatocellular carcinoma. STAR protocols\| PubMed ID: 36595904	2022